|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61P 9/00 | (2018.01) |
| A61K 47/60 | (2017.01) | ||
| A61K 47/61 | (2017.01) | ||
| A61P 7/02 | (2018.01) | ||
| A61P 37/04 | (2018.01) | ||
| A61P 43/00 | (2018.01) | ||
| A61P 7/04 | (2018.01) | ||
| A61P 5/24 | (2018.01) | ||
| A61P 7/00 | (2018.01) | ||
| A61P 1/16 | (2018.01) | ||
| A61P 35/02 | (2018.01) | ||
| A61P 19/10 | (2018.01) | ||
| A61P 37/02 | (2018.01) | ||
| A61P 7/06 | (2018.01) | ||
| A61P 25/00 | (2018.01) | ||
| A61K 47/60 | (2017.08) | ||
| A61P 19/08 | (2018.01) | ||
| A61P 9/02 | (2018.01) | ||
| A61P 17/00 | (2018.01) | ||
| A61P 3/10 | (2018.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 5/06 | (2018.01) | ||
| A61P 5/00 | (2018.01) | ||
| A61K 47/61 | (2017.08) | ||
| A61P 15/08 | (2018.01) |
| (11) | Number of the document | 3505186 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18208032.5 |
| Date of filing the European patent application | 2011-07-29 | |
| (97) | Date of publication of the European application | 2019-07-03 |
| (45) | Date of publication and mention of the grant of the patent | 2022-01-12 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 36918610 P | 2010-07-30 | US |
| (72) |
Siekmann, Jürgen, Dr. , AT
Haider, Stefan , AT
Rottensteiner, Hanspeter , AT
Ivens, Andreas , CH
Turecek, Peter, Dr. , AT
Zoechling, Oliver , AT
|
| (73) |
Takeda Pharmaceutical Company Limited ,
1-1, Doshomachi 4-chome,
Chuo-ku,, Osaka-shi, Osaka,
JP
|
| (54) | NUCLEOPHILIC CATALYSTS FOR OXIME LINKAGE |
| NUCLEOPHILIC CATALYSTS FOR OXIME LINKAGE |